Literature DB >> 29712509

Systematic Review and Meta-analysis of SNOT-22 Outcomes after Surgery for Chronic Rhinosinusitis with Nasal Polyposis.

Phong T Le1, Zachary M Soler1, Rabun Jones1, Jose L Mattos1,2, Shaun A Nguyen1, Rodney J Schlosser1.   

Abstract

Objective Wide variation exists regarding reported outcomes after endoscopic sinus surgery (ESS) for chronic rhinosinusitis with nasal polyps (CRSwNP). This study seeks to combine data across studies to generate a summary measure and explore factors that might lead to variation. Data Sources OVID Medline, Scopus, EbscoHost, Database of Abstracts and Reviews of Effects, Health Technology Assessment, and National Health Service Economic Evaluation Database. Review Methods A search was performed following the PRISMA guidelines. Two independent researchers conducted a search using the mentioned data sources. Studies published before August 29, 2016, that involved ESS to treat CRSwNP were included. Mean changes in Sinonasal Outcome Test-22 (SNOT-22) scores were determined through metaregression of the following independent variables: publication year, sex, age, allergy status, asthma, tobacco use, prior surgery, follow-up length, and preoperative SNOT-22. Results Fifteen articles with 3048 patients treated with ESS met inclusion criteria. Pooled analyses of SNOT-22 scores revealed a mean change of 23.0 points (95% CI, 20.2-25.8; P < .001). A metaregression of patient factor effects on the mean change of SNOT-22 scores demonstrated that age ( r = 0.71, P = .01), asthma ( r = 0.21, P = .01), prior ESS ( r = 0.29, P = .01), and preoperative SNOT-22 score ( r = 0.4, P < .01) correlated with greater improvement in SNOT-22 scores. Tobacco use ( r = -0.91, P = .01) and longer lengths of follow-up ( r = -0.45, P < .01) were associated with less improvement in SNOT-22 scores. Conclusions Quality-of-life outcomes are significantly improved after ESS among patients with CRSwNP. Patient-specific factors may affect the degree of SNOT-22 change after surgery.

Entities:  

Keywords:  22-item Sinonasal Outcome Test; chronic rhinosinusitis; meta-analysis; nasal polyps; quality improvement; quality of life

Mesh:

Year:  2018        PMID: 29712509     DOI: 10.1177/0194599818773065

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  10 in total

1.  Efficacy of steroid-eluting stents in management of chronic rhinosinusitis after endoscopic sinus surgery: updated meta-analysis.

Authors:  Khodayar Goshtasbi; Mehdi Abouzari; Arash Abiri; Tyler Yasaka; Ronald Sahyouni; Benjamin Bitner; Bobby A Tajudeen; Edward C Kuan
Journal:  Int Forum Allergy Rhinol       Date:  2019-09-20       Impact factor: 3.858

Review 2.  The Role of Staphylococcus aureus in Patients with Chronic Sinusitis and Nasal Polyposis.

Authors:  Thad W Vickery; Vijay R Ramakrishnan; Jeffrey D Suh
Journal:  Curr Allergy Asthma Rep       Date:  2019-03-11       Impact factor: 4.806

3.  Advanced age adversely affects chronic rhinosinusitis surgical outcomes.

Authors:  Kristen L Yancey; Anne S Lowery; Rakesh K Chandra; Naweed I Chowdhury; Justin H Turner
Journal:  Int Forum Allergy Rhinol       Date:  2019-08-27       Impact factor: 3.858

4.  Socioeconomic status impacts postoperative productivity loss and health utility changes in refractory chronic rhinosinusitis.

Authors:  Daniel M Beswick; Jess C Mace; Zachary M Soler; Luke Rudmik; Jeremiah A Alt; Kristine A Smith; Kara Y Detwiller; Vijay R Ramakrishnan; Timothy L Smith
Journal:  Int Forum Allergy Rhinol       Date:  2019-06-27       Impact factor: 3.858

5.  The SNOT-22 factorial structure in European patients with chronic rhinosinusitis: new clinical insights.

Authors:  D Dejaco; D Riedl; A Huber; R Moschen; A I Giotakis; L Bektic-Tadic; T Steinbichler; P Kahler; H Riechelmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-02-09       Impact factor: 2.503

Review 6.  Chronic Rhinosinusitis with Nasal Polyps: Targeting IgE with Anti-IgE Omalizumab Therapy.

Authors:  Harsha H Kariyawasam; Louisa K James
Journal:  Drug Des Devel Ther       Date:  2020-12-10       Impact factor: 4.162

7.  Clinical evaluation and nasoendoscopic scores of patients with chronic rhinosinusitis in Ilorin, Nigeria.

Authors:  Samuel Oluyomi Ayodele; Olushola Abdulrhaman Afolabi; Segun Segun-Busari; Habeeb Kayodele Omokanye; Biodun Sulyman Alabi; Foluwasayo Emmanuel Ologe
Journal:  Pan Afr Med J       Date:  2021-04-23

Review 8.  Clinical Research Needs for the Management of Chronic Rhinosinusitis with Nasal Polyps in the New Era of Biologics: A National Institute of Allergy and Infectious Diseases Workshop.

Authors:  Robert Naclerio; Fuad Baroody; Claus Bachert; Benjamin Bleier; Larry Borish; Erica Brittain; Geoffrey Chupp; Anat Fisher; Wytske Fokkens; Philippe Gevaert; David Kennedy; Jean Kim; Tanya M Laidlaw; Jake J Lee; Jay F Piccirillo; Jayant M Pinto; Lauren T Roland; Robert P Schleimer; Rodney J Schlosser; Julie M Schwaninger; Timothy L Smith; Bruce K Tan; Ming Tan; Elina Toskala; Sally Wenzel; Alkis Togias
Journal:  J Allergy Clin Immunol Pract       Date:  2020-03-04

9.  Cumulative comorbidity burden does not worsen outcomes in management of chronic rhinosinusitis.

Authors:  Amarbir S Gill; Jess C Mace; Ryan Rimmer; Vijay R Ramakrishnan; Daniel M Beswick; Zachary M Soler; James Manor; Richard R Orlandi; Timothy L Smith; Jeremiah A Alt
Journal:  Int Forum Allergy Rhinol       Date:  2021-07-14       Impact factor: 3.858

10.  Prognostic value of the Sinonasal Outcome Test 22 (SNOT-22) in chronic rhinosinusitis.

Authors:  Stefania Gallo; Federico Russo; Francesco Mozzanica; Andrea Preti; Francesco Bandi; Cecilia Costantino; Roberto Gera; Francesco Ottaviani; Paolo Castelnuovo
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-04       Impact factor: 2.124

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.